AI Doctor's helper: could a smart system improve heart and diabetes care?
NCT ID NCT07350486
First seen Jun 27, 2026 · Last updated Sep 04, 2026 · Updated 1 time
Summary
This study will test whether an artificial intelligence (AI) system can help community doctors better manage patients who have high blood pressure along with diabetes or high cholesterol. About 6,800 adults will be split into two groups: one where doctors use the AI tool to guide treatment and follow-up, and another where they receive usual care. The goal is to see if the AI approach helps more patients reach healthy targets for blood pressure, blood sugar, and cholesterol.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Large language model (AI) software that helps community doctors coordinate care for multiple conditions
- What this could lead to
- If it works, this could show that AI-assisted community care improves control of blood pressure, blood sugar, and cholesterol in people with multiple conditions.
- What could go wrong
- This trial has not started yet and is testing a new AI system, so results are uncertain. The AI may not work as well in real-world community settings or may have technical issues.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 6,800 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
May 2026
- Expected to finish
-
Apr 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
40 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Participating communities must meet all of the following criteria: * Have a designated community physician responsible for primary care who is capable of using a smartphone with stable internet access for clinical communication and LLM-assisted management; * No plan for administrative merger or restructuring within the next three years; * Located at least 2 kilometers away from adjacent participating communities (to minimize contamination between clusters). Eligible participants must fulfill all of the following conditions: * Aged 40 years or older; * Uncontrolled hypertension, defined as systolic blood pressure (SBP) ≥140 mmHg or diastolic blood pressure (DBP) ≥ 90 mmHg; * Coexisting diabetes (HbA1c ≥ 7.0%) or coexisting dyslipidemia (LDL-C ≥ 3.4 mmol/L\[130 mg/dL\]); * Able to use a smartphone independently or with assistance from family members; * Has resided in the participating community for at least 6 months; * Has no plan to relocate in the next 3 years; * Enrolled in basic medical insurance for urban and rural residents, employee medical insurance, or the New Rural Cooperative Medical Scheme; * Not currently pregnant or planning pregnancy during the study period; * Free from malignant tumors and deemed to have a life expectancy of at least 3 years, as judged by study physicians; * Willing and able to provide written informed consent. Exclusion Criteria:No specific exclusion criteria.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Diabetes are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Binhai New Area
Tianjin, China
-
Cangzhou
Cangzhou, Hebei, China
-
Dawa District
Panjin, Liaoning, China
-
Shenyang
Shenyang, Liaoning, China
-
Wujiang District
Suzhou, Jiangsu, China
-
Yiwu
Jinzhou, Zhejiang, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gut bacteria may hold clues to dozens of diseases
- Heartbeat test aims to catch hidden nerve damage in diabetes
- Inflatable leg cuffs tested as a Two-for-One therapy for high blood pressure and erectile dysfunction
- Can Home-Delivered meals help control diabetes?
- Can nurses and home monitors tame high blood pressure?
- Smoking and diet may shape cholesterol in mexican adults